Pulmonary inflammation is associated with the development of
bronchopulmonary dysplasia in premature infants. We have previously shown that perinatal pulmonary expression of human IL-1beta is sufficient to cause a
lung disease similar to
bronchopulmonary dysplasia, characterized by
inflammation, impaired alveolarization, poor postnatal growth, and increased mortality in infant mice. The
alphavbeta6 integrin plays a critical role in regulating
inflammation in the adult lung. To study the role of the
beta6 integrin subunit in neonatal inflammatory
lung disease, we compared the pulmonary development in IL-1beta-expressing infant mice with wild-type or null
beta6 integrin loci. Absence of the
beta6 integrin subunit decreased the mortality and improved the postnatal growth of IL-1beta-expressing pups. The disrupted alveolar development of IL-1beta-expressing mice was improved by
beta6 integrin deficiency. IL-1beta-expressing beta6(-/-) pups had shorter alveolar chord length and thinner alveolar walls than IL-1beta-expressing beta6(+/+) pups. In addition, the absence of the
beta6 integrin subunit reduced IL-1beta-induced neutrophil and macrophage infiltration into the alveolar spaces.
beta6 integrin subunit deficiency suppressed
inflammation and goblet cell
hyperplasia in the airways and alleviated
airway remodeling in IL-1beta-expressing mice. The expression of the
chemoattractant proteins, keratinocyte-derived
chemokine, macrophage-inflammatory protein-2,
calgranulin A, and
calgranulin B, of
osteopontin, and of the
chitinase-like
lectins, Ym1 and Ym2, was lower in IL-1beta-expressing beta6(-/-) than in IL-1beta-expressing beta6(+/+) mice. We conclude that absence of the
beta6 integrin subunit protects the infant murine lung against IL-1beta-induced
inflammation and injury.